

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine metabolic process (GO:0006553) | 5.41769855 |
| 2 | lysine catabolic process (GO:0006554) | 5.41769855 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.17160363 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.17160363 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 5.08858098 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.08858098 |
| 7 | cysteine metabolic process (GO:0006534) | 5.07495395 |
| 8 | glyoxylate metabolic process (GO:0046487) | 5.00653582 |
| 9 | proline biosynthetic process (GO:0006561) | 4.93997760 |
| 10 | COPI coating of Golgi vesicle (GO:0048205) | 4.82303898 |
| 11 | Golgi transport vesicle coating (GO:0048200) | 4.82303898 |
| 12 | aromatic amino acid family catabolic process (GO:0009074) | 4.72628888 |
| 13 | regulation of translational fidelity (GO:0006450) | 4.67492046 |
| 14 | DNA unwinding involved in DNA replication (GO:0006268) | 4.45814271 |
| 15 | sulfur amino acid catabolic process (GO:0000098) | 4.45598054 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.42331627 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 4.42331627 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 4.42331627 |
| 19 | formation of translation preinitiation complex (GO:0001731) | 4.36747888 |
| 20 | L-serine metabolic process (GO:0006563) | 4.34343233 |
| 21 | kynurenine metabolic process (GO:0070189) | 4.31671300 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.30821305 |
| 23 | protoporphyrinogen IX metabolic process (GO:0046501) | 4.28149416 |
| 24 | drug transmembrane transport (GO:0006855) | 4.27510114 |
| 25 | urate metabolic process (GO:0046415) | 4.26211584 |
| 26 | valine metabolic process (GO:0006573) | 4.25568560 |
| 27 | establishment of integrated proviral latency (GO:0075713) | 4.24928117 |
| 28 | tryptophan metabolic process (GO:0006568) | 4.19978198 |
| 29 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.09129553 |
| 30 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 4.07003788 |
| 31 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.06220328 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 4.00674424 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 4.00549560 |
| 34 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.93726833 |
| 35 | drug transport (GO:0015893) | 3.92240897 |
| 36 | glycine metabolic process (GO:0006544) | 3.92036199 |
| 37 | 2-oxoglutarate metabolic process (GO:0006103) | 3.90873613 |
| 38 | serine family amino acid metabolic process (GO:0009069) | 3.89372062 |
| 39 | urea cycle (GO:0000050) | 3.86072756 |
| 40 | urea metabolic process (GO:0019627) | 3.86072756 |
| 41 | homocysteine metabolic process (GO:0050667) | 3.84070313 |
| 42 | NADH metabolic process (GO:0006734) | 3.82624401 |
| 43 | DNA strand elongation (GO:0022616) | 3.81748937 |
| 44 | tricarboxylic acid metabolic process (GO:0072350) | 3.80720209 |
| 45 | amino-acid betaine metabolic process (GO:0006577) | 3.79975237 |
| 46 | serine family amino acid biosynthetic process (GO:0009070) | 3.79694862 |
| 47 | heme biosynthetic process (GO:0006783) | 3.79255827 |
| 48 | protein maturation by protein folding (GO:0022417) | 3.75894024 |
| 49 | mitotic chromosome condensation (GO:0007076) | 3.74114937 |
| 50 | bile acid biosynthetic process (GO:0006699) | 3.73867797 |
| 51 | ethanol oxidation (GO:0006069) | 3.67420842 |
| 52 | cellular modified amino acid catabolic process (GO:0042219) | 3.60917766 |
| 53 | histone arginine methylation (GO:0034969) | 3.58931386 |
| 54 | nitrogen cycle metabolic process (GO:0071941) | 3.57355868 |
| 55 | ribosomal small subunit biogenesis (GO:0042274) | 3.55050527 |
| 56 | establishment of viral latency (GO:0019043) | 3.53943796 |
| 57 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.53275288 |
| 58 | negative regulation of fibrinolysis (GO:0051918) | 3.50429699 |
| 59 | heme metabolic process (GO:0042168) | 3.50416813 |
| 60 | glucose catabolic process (GO:0006007) | 3.49413919 |
| 61 | short-chain fatty acid metabolic process (GO:0046459) | 3.49135955 |
| 62 | drug catabolic process (GO:0042737) | 3.45764632 |
| 63 | regulation of cholesterol homeostasis (GO:2000188) | 3.45761494 |
| 64 | aspartate family amino acid catabolic process (GO:0009068) | 3.45045808 |
| 65 | alpha-amino acid catabolic process (GO:1901606) | 3.44949843 |
| 66 | aromatic amino acid family metabolic process (GO:0009072) | 3.43033208 |
| 67 | porphyrin-containing compound biosynthetic process (GO:0006779) | 3.42095736 |
| 68 | protein complex localization (GO:0031503) | 3.38956665 |
| 69 | negative regulation of sterol transport (GO:0032372) | 3.34453569 |
| 70 | negative regulation of cholesterol transport (GO:0032375) | 3.34453569 |
| 71 | fatty acid beta-oxidation (GO:0006635) | 3.32494324 |
| 72 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.29516121 |
| 73 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.29516121 |
| 74 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.28825309 |
| 75 | high-density lipoprotein particle remodeling (GO:0034375) | 3.28588584 |
| 76 | cellular amino acid catabolic process (GO:0009063) | 3.28340600 |
| 77 | plasma lipoprotein particle assembly (GO:0034377) | 3.27291995 |
| 78 | protein carboxylation (GO:0018214) | 3.24826774 |
| 79 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.24826774 |
| 80 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.23680717 |
| 81 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.23556821 |
| 82 | peptidyl-arginine N-methylation (GO:0035246) | 3.22537132 |
| 83 | peptidyl-arginine methylation (GO:0018216) | 3.22537132 |
| 84 | fatty acid oxidation (GO:0019395) | 3.22066678 |
| 85 | tricarboxylic acid cycle (GO:0006099) | 3.21327077 |
| 86 | pentose metabolic process (GO:0019321) | 3.18857065 |
| 87 | porphyrin-containing compound metabolic process (GO:0006778) | 3.17611331 |
| 88 | carnitine metabolic process (GO:0009437) | 3.17314060 |
| 89 | heterochromatin organization (GO:0070828) | 3.15282565 |
| 90 | lipid oxidation (GO:0034440) | 3.15226347 |
| 91 | cellular ketone body metabolic process (GO:0046950) | 3.15127212 |
| 92 | response to mercury ion (GO:0046689) | 3.13939116 |
| 93 | regulation of triglyceride catabolic process (GO:0010896) | 3.13377123 |
| 94 | IMP biosynthetic process (GO:0006188) | 3.10728197 |
| 95 | acetyl-CoA metabolic process (GO:0006084) | 3.10504971 |
| 96 | flavonoid metabolic process (GO:0009812) | 3.10124679 |
| 97 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.08931727 |
| 98 | protein retention in ER lumen (GO:0006621) | 3.08339848 |
| 99 | regulation of protein activation cascade (GO:2000257) | 3.08167735 |
| 100 | bile acid metabolic process (GO:0008206) | 3.08051413 |
| 101 | branched-chain amino acid metabolic process (GO:0009081) | 3.08011323 |
| 102 | GDP-mannose metabolic process (GO:0019673) | 3.07860878 |
| 103 | oxaloacetate metabolic process (GO:0006107) | 3.07592057 |
| 104 | tetrapyrrole biosynthetic process (GO:0033014) | 3.07188824 |
| 105 | mitochondrial fusion (GO:0008053) | 3.06658942 |
| 106 | complement activation, alternative pathway (GO:0006957) | 3.06144266 |
| 107 | reverse cholesterol transport (GO:0043691) | 3.04120847 |
| 108 | glutamate metabolic process (GO:0006536) | 3.03430201 |
| 109 | regulation of fibrinolysis (GO:0051917) | 3.03424280 |
| 110 | indolalkylamine metabolic process (GO:0006586) | 3.02939736 |
| 111 | DNA replication initiation (GO:0006270) | 3.01505344 |
| 112 | organic acid catabolic process (GO:0016054) | 3.00714332 |
| 113 | carboxylic acid catabolic process (GO:0046395) | 3.00714332 |
| 114 | fatty acid catabolic process (GO:0009062) | 3.00337844 |
| 115 | exogenous drug catabolic process (GO:0042738) | 3.00035377 |
| 116 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.00012043 |
| 117 | monosaccharide biosynthetic process (GO:0046364) | 2.99431129 |
| 118 | protein-lipid complex assembly (GO:0065005) | 2.99184642 |
| 119 | benzene-containing compound metabolic process (GO:0042537) | 2.98874510 |
| 120 | pentose-phosphate shunt (GO:0006098) | 2.98613737 |
| 121 | phospholipid efflux (GO:0033700) | 2.98360083 |
| 122 | folic acid metabolic process (GO:0046655) | 2.97696125 |
| 123 | aldehyde catabolic process (GO:0046185) | 2.97047099 |
| 124 | monocarboxylic acid catabolic process (GO:0072329) | 2.95135265 |
| 125 | tRNA aminoacylation for protein translation (GO:0006418) | 2.95087359 |
| 126 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.94070456 |
| 127 | regulation of cholesterol esterification (GO:0010872) | 2.93017723 |
| 128 | ribosomal small subunit assembly (GO:0000028) | 2.91575597 |
| 129 | regulation of complement activation (GO:0030449) | 2.89587948 |
| 130 | regulation of mitochondrial translation (GO:0070129) | 2.88488391 |
| 131 | oxidative phosphorylation (GO:0006119) | 2.88487299 |
| 132 | viral transcription (GO:0019083) | 2.88171469 |
| 133 | IMP metabolic process (GO:0046040) | 2.88139145 |
| 134 | mitochondrial DNA metabolic process (GO:0032042) | 2.87720623 |
| 135 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.87419152 |
| 136 | ribosomal large subunit biogenesis (GO:0042273) | 2.86839470 |
| 137 | proline metabolic process (GO:0006560) | 2.85321257 |
| 138 | regulation of translational termination (GO:0006449) | 2.85159902 |
| 139 | protein-lipid complex remodeling (GO:0034368) | 2.82769437 |
| 140 | macromolecular complex remodeling (GO:0034367) | 2.82769437 |
| 141 | plasma lipoprotein particle remodeling (GO:0034369) | 2.82769437 |
| 142 | cellular biogenic amine catabolic process (GO:0042402) | 2.82186315 |
| 143 | amine catabolic process (GO:0009310) | 2.82186315 |
| 144 | NADPH regeneration (GO:0006740) | 2.82050149 |
| 145 | nuclear pore complex assembly (GO:0051292) | 2.81784610 |
| 146 | telomere maintenance via recombination (GO:0000722) | 2.81532324 |
| 147 | plasma lipoprotein particle clearance (GO:0034381) | 2.81361903 |
| 148 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.80681401 |
| 149 | amino acid activation (GO:0043038) | 2.80301858 |
| 150 | tRNA aminoacylation (GO:0043039) | 2.80301858 |
| 151 | cellular glucuronidation (GO:0052695) | 2.78985731 |
| 152 | one-carbon metabolic process (GO:0006730) | 2.78092218 |
| 153 | maturation of SSU-rRNA (GO:0030490) | 2.77708331 |
| 154 | mitotic sister chromatid segregation (GO:0000070) | 2.75536124 |
| 155 | cellular protein complex localization (GO:0034629) | 2.75073926 |
| 156 | gluconeogenesis (GO:0006094) | 2.75066801 |
| 157 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.74975803 |
| 158 | glucose 6-phosphate metabolic process (GO:0051156) | 2.74770005 |
| 159 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.73825576 |
| 160 | translational termination (GO:0006415) | 2.72043761 |
| 161 | biotin metabolic process (GO:0006768) | 2.71047439 |
| 162 | translational elongation (GO:0006414) | 2.70910728 |
| 163 | hexose biosynthetic process (GO:0019319) | 2.70720179 |
| 164 | mitotic nuclear envelope disassembly (GO:0007077) | 2.69678358 |
| 165 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.67913569 |
| 166 | mitotic recombination (GO:0006312) | 2.65688419 |
| 167 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.65398808 |
| 168 | nuclear envelope reassembly (GO:0031468) | 2.64029165 |
| 169 | mitotic nuclear envelope reassembly (GO:0007084) | 2.64029165 |
| 170 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.63620963 |
| 171 | DNA duplex unwinding (GO:0032508) | 2.60378744 |
| 172 | protein localization to chromosome, centromeric region (GO:0071459) | 2.59485975 |
| 173 | rRNA transcription (GO:0009303) | 2.55511602 |
| 174 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.54471428 |
| 175 | ncRNA 3-end processing (GO:0043628) | 2.54272777 |
| 176 | nucleobase biosynthetic process (GO:0046112) | 2.52922754 |
| 177 | glycolytic process (GO:0006096) | 2.52380974 |
| 178 | NADP metabolic process (GO:0006739) | 2.52033416 |
| 179 | base-excision repair (GO:0006284) | 2.51794826 |
| 180 | folic acid-containing compound metabolic process (GO:0006760) | 2.51765491 |
| 181 | translational initiation (GO:0006413) | 2.51745010 |
| 182 | ribosome biogenesis (GO:0042254) | 2.50062875 |
| 183 | ribosome assembly (GO:0042255) | 2.48772654 |
| 184 | protein targeting to ER (GO:0045047) | 2.47785333 |
| 185 | cotranslational protein targeting to membrane (GO:0006613) | 2.46762997 |
| 186 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.46708733 |
| 187 | nuclear envelope disassembly (GO:0051081) | 2.44900457 |
| 188 | membrane disassembly (GO:0030397) | 2.44900457 |
| 189 | maternal placenta development (GO:0001893) | 2.44608490 |
| 190 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.44331419 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.10671029 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.10212174 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.84603795 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.54429300 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.49362124 |
| 6 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 3.00033394 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.89189637 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.89059575 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.84976164 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.80101601 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.60873010 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.43978555 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.13103031 |
| 14 | GATA1_22025678_ChIP-Seq_K562_Human | 2.08363542 |
| 15 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.05693479 |
| 16 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.04250265 |
| 17 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.00813170 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.85668915 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.84447481 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81803259 |
| 21 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.81457366 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78475205 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.77605185 |
| 24 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.72868109 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.67818966 |
| 26 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.66704363 |
| 27 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.65179445 |
| 28 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63922139 |
| 29 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.62792289 |
| 30 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.61616995 |
| 31 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.61580415 |
| 32 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.60440993 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.59618251 |
| 34 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59474125 |
| 35 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.55237606 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.55068215 |
| 37 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.53395398 |
| 38 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.50695653 |
| 39 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.50215793 |
| 40 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.49988794 |
| 41 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.49874849 |
| 42 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.47513158 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47189122 |
| 44 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.43991437 |
| 45 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.43646074 |
| 46 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.42388856 |
| 47 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.41842204 |
| 48 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.40587291 |
| 49 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.40532944 |
| 50 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.40240747 |
| 51 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.39908980 |
| 52 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.33381800 |
| 53 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.32939486 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.32281623 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.32078551 |
| 56 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.30202634 |
| 57 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.29493108 |
| 58 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.29000590 |
| 59 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.28655874 |
| 60 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.26021976 |
| 61 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.24517734 |
| 62 | UTX_26944678_Chip-Seq_JUKART_Human | 1.24124406 |
| 63 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.22376459 |
| 64 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21834934 |
| 65 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.21693143 |
| 66 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.21469796 |
| 67 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.21345648 |
| 68 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20119376 |
| 69 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.20010544 |
| 70 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.19665579 |
| 71 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.19283327 |
| 72 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.18787660 |
| 73 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.18115587 |
| 74 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18019209 |
| 75 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17925777 |
| 76 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.17461825 |
| 77 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.17459510 |
| 78 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16755894 |
| 79 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.16465270 |
| 80 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.15597850 |
| 81 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.15514391 |
| 82 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.15181123 |
| 83 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.14421282 |
| 84 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.13641047 |
| 85 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.12565480 |
| 86 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.12117728 |
| 87 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.12060552 |
| 88 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11777452 |
| 89 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.11661615 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10757573 |
| 91 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.10333019 |
| 92 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10216676 |
| 93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10097472 |
| 94 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.09520178 |
| 95 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.09187998 |
| 96 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08855485 |
| 97 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.08057488 |
| 98 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.08020158 |
| 99 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.07751429 |
| 100 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.07189139 |
| 101 | * P68_20966046_ChIP-Seq_HELA_Human | 1.06865065 |
| 102 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.06727683 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06498786 |
| 104 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.06031942 |
| 105 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.05279566 |
| 106 | MYB_26560356_Chip-Seq_TH1_Human | 1.04830204 |
| 107 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.04516855 |
| 108 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.04420759 |
| 109 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03802696 |
| 110 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.03617418 |
| 111 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03600301 |
| 112 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.03532969 |
| 113 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.02903352 |
| 114 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.02796587 |
| 115 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.01188083 |
| 116 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.01062057 |
| 117 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.00416961 |
| 118 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.99641538 |
| 119 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.99327498 |
| 120 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.99245010 |
| 121 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.99140716 |
| 122 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.98754184 |
| 123 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.98595022 |
| 124 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.98342048 |
| 125 | * MAF_26560356_Chip-Seq_TH2_Human | 0.97819180 |
| 126 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.97456651 |
| 127 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.97331849 |
| 128 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96839574 |
| 129 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.95366665 |
| 130 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.95309728 |
| 131 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.94913154 |
| 132 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94813744 |
| 133 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.93680667 |
| 134 | * MYB_26560356_Chip-Seq_TH2_Human | 0.93369566 |
| 135 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.92933844 |
| 136 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.92471603 |
| 137 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.92375772 |
| 138 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.91919374 |
| 139 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.91556716 |
| 140 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.91279497 |
| 141 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.90608815 |
| 142 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90597852 |
| 143 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90014750 |
| 144 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.89102222 |
| 145 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.88917467 |
| 146 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.88643409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.01006827 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.55616727 |
| 3 | MP0005365_abnormal_bile_salt | 3.97848289 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.83714106 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.55991841 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.30656983 |
| 7 | MP0003111_abnormal_nucleus_morphology | 3.17899981 |
| 8 | MP0010234_abnormal_vibrissa_follicle | 3.16629638 |
| 9 | MP0004957_abnormal_blastocyst_morpholog | 3.05476597 |
| 10 | MP0003656_abnormal_erythrocyte_physiolo | 2.79836853 |
| 11 | MP0009840_abnormal_foam_cell | 2.71743755 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.69486042 |
| 13 | MP0001849_ear_inflammation | 2.61748897 |
| 14 | MP0008260_abnormal_autophagy | 2.58080468 |
| 15 | MP0003252_abnormal_bile_duct | 2.56933289 |
| 16 | MP0005332_abnormal_amino_acid | 2.56830495 |
| 17 | MP0005083_abnormal_biliary_tract | 2.53575965 |
| 18 | MP0004233_abnormal_muscle_weight | 2.52169801 |
| 19 | MP0003077_abnormal_cell_cycle | 2.36491866 |
| 20 | MP0000537_abnormal_urethra_morphology | 2.32062991 |
| 21 | MP0010329_abnormal_lipoprotein_level | 2.32024684 |
| 22 | MP0008932_abnormal_embryonic_tissue | 2.31775504 |
| 23 | MP0001730_embryonic_growth_arrest | 2.29794697 |
| 24 | MP0001666_abnormal_nutrient_absorption | 2.23804582 |
| 25 | MP0004147_increased_porphyrin_level | 2.17389276 |
| 26 | MP0004185_abnormal_adipocyte_glucose | 2.14979201 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 2.11370293 |
| 28 | MP0009643_abnormal_urine_homeostasis | 2.02491681 |
| 29 | MP0003941_abnormal_skin_development | 2.01169137 |
| 30 | MP0004019_abnormal_vitamin_homeostasis | 2.00138732 |
| 31 | MP0001661_extended_life_span | 2.00126262 |
| 32 | MP0002254_reproductive_system_inflammat | 1.97822102 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.93131268 |
| 34 | MP0004858_abnormal_nervous_system | 1.92052350 |
| 35 | MP0010030_abnormal_orbit_morphology | 1.90614267 |
| 36 | MP0000609_abnormal_liver_physiology | 1.87800254 |
| 37 | MP0002796_impaired_skin_barrier | 1.86378119 |
| 38 | MP0003566_abnormal_cell_adhesion | 1.84486713 |
| 39 | MP0005501_abnormal_skin_physiology | 1.83637776 |
| 40 | MP0003195_calcinosis | 1.83469536 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.78723915 |
| 42 | MP0005636_abnormal_mineral_homeostasis | 1.73944556 |
| 43 | MP0003186_abnormal_redox_activity | 1.73673958 |
| 44 | MP0009672_abnormal_birth_weight | 1.69490312 |
| 45 | MP0008007_abnormal_cellular_replicative | 1.65851417 |
| 46 | MP0000350_abnormal_cell_proliferation | 1.60311978 |
| 47 | MP0002080_prenatal_lethality | 1.55231394 |
| 48 | MP0008058_abnormal_DNA_repair | 1.53339840 |
| 49 | MP0002877_abnormal_melanocyte_morpholog | 1.51440804 |
| 50 | MP0001764_abnormal_homeostasis | 1.49616493 |
| 51 | MP0000685_abnormal_immune_system | 1.45877942 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 1.45484969 |
| 53 | MP0005380_embryogenesis_phenotype | 1.43257143 |
| 54 | MP0001672_abnormal_embryogenesis/_devel | 1.43257143 |
| 55 | MP0005076_abnormal_cell_differentiation | 1.43254665 |
| 56 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.43001945 |
| 57 | MP0003123_paternal_imprinting | 1.41969856 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 1.41160076 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.36319378 |
| 60 | MP0001835_abnormal_antigen_presentation | 1.35922420 |
| 61 | MP0000598_abnormal_liver_morphology | 1.33896737 |
| 62 | MP0003984_embryonic_growth_retardation | 1.33753320 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 1.33714952 |
| 64 | MP0005464_abnormal_platelet_physiology | 1.33414938 |
| 65 | MP0003453_abnormal_keratinocyte_physiol | 1.31143317 |
| 66 | MP0005058_abnormal_lysosome_morphology | 1.31082410 |
| 67 | MP0000313_abnormal_cell_death | 1.29203806 |
| 68 | MP0008469_abnormal_protein_level | 1.26313237 |
| 69 | MP0002088_abnormal_embryonic_growth/wei | 1.25381377 |
| 70 | MP0001697_abnormal_embryo_size | 1.24106198 |
| 71 | MP0000747_muscle_weakness | 1.23118171 |
| 72 | MP0003436_decreased_susceptibility_to | 1.21853016 |
| 73 | MP0002136_abnormal_kidney_physiology | 1.20079631 |
| 74 | MP0003315_abnormal_perineum_morphology | 1.19855062 |
| 75 | MP0002396_abnormal_hematopoietic_system | 1.18676911 |
| 76 | MP0001756_abnormal_urination | 1.16947034 |
| 77 | MP0000358_abnormal_cell_content/ | 1.16656586 |
| 78 | MP0000678_abnormal_parathyroid_gland | 1.15370158 |
| 79 | MP0000751_myopathy | 1.15298614 |
| 80 | MP0002085_abnormal_embryonic_tissue | 1.10193174 |
| 81 | MP0003868_abnormal_feces_composition | 1.08778228 |
| 82 | MP0006054_spinal_hemorrhage | 1.08736232 |
| 83 | MP0004043_abnormal_pH_regulation | 1.07775869 |
| 84 | MP0002086_abnormal_extraembryonic_tissu | 1.07702615 |
| 85 | MP0009764_decreased_sensitivity_to | 1.04784625 |
| 86 | MP0005330_cardiomyopathy | 1.04731323 |
| 87 | MP0005257_abnormal_intraocular_pressure | 1.04715467 |
| 88 | MP0000579_abnormal_nail_morphology | 1.04048116 |
| 89 | MP0000858_altered_metastatic_potential | 1.03936065 |
| 90 | MP0005397_hematopoietic_system_phenotyp | 1.03762523 |
| 91 | MP0001545_abnormal_hematopoietic_system | 1.03762523 |
| 92 | MP0005220_abnormal_exocrine_pancreas | 1.01664163 |
| 93 | MP0000689_abnormal_spleen_morphology | 1.00904411 |
| 94 | MP0002089_abnormal_postnatal_growth/wei | 1.00647102 |
| 95 | MP0001216_abnormal_epidermal_layer | 0.99209029 |
| 96 | MP0005025_abnormal_response_to | 0.98744253 |
| 97 | MP0002166_altered_tumor_susceptibility | 0.97691139 |
| 98 | MP0010307_abnormal_tumor_latency | 0.97417729 |
| 99 | MP0009763_increased_sensitivity_to | 0.97022732 |
| 100 | MP0005666_abnormal_adipose_tissue | 0.95387439 |
| 101 | MP0001845_abnormal_inflammatory_respons | 0.95269075 |
| 102 | MP0001853_heart_inflammation | 0.93918510 |
| 103 | MP0002060_abnormal_skin_morphology | 0.93499289 |
| 104 | MP0002722_abnormal_immune_system | 0.93492687 |
| 105 | MP0009785_altered_susceptibility_to | 0.93338355 |
| 106 | MP0001800_abnormal_humoral_immune | 0.92876548 |
| 107 | MP0010155_abnormal_intestine_physiology | 0.92510368 |
| 108 | MP0005384_cellular_phenotype | 0.92494609 |
| 109 | MP0005621_abnormal_cell_physiology | 0.91342299 |
| 110 | MP0000490_abnormal_crypts_of | 0.90931684 |
| 111 | MP0002084_abnormal_developmental_patter | 0.90853668 |
| 112 | MP0001873_stomach_inflammation | 0.90817766 |
| 113 | MP0001765_abnormal_ion_homeostasis | 0.90664558 |
| 114 | MP0002398_abnormal_bone_marrow | 0.90389281 |
| 115 | MP0003724_increased_susceptibility_to | 0.90138392 |
| 116 | MP0009642_abnormal_blood_homeostasis | 0.89961312 |
| 117 | MP0003763_abnormal_thymus_physiology | 0.89339511 |
| 118 | MP0005408_hypopigmentation | 0.86843531 |
| 119 | MP0000566_synostosis | 0.86449737 |
| 120 | MP0002098_abnormal_vibrissa_morphology | 0.86338111 |
| 121 | MP0008961_abnormal_basal_metabolism | 0.86201250 |
| 122 | MP0005670_abnormal_white_adipose | 0.85951135 |
| 123 | MP0002269_muscular_atrophy | 0.84785849 |
| 124 | MP0002019_abnormal_tumor_incidence | 0.84613386 |
| 125 | MP0002697_abnormal_eye_size | 0.84562363 |
| 126 | MP0004264_abnormal_extraembryonic_tissu | 0.83943771 |
| 127 | MP0010352_gastrointestinal_tract_polyps | 0.83735106 |
| 128 | MP0003786_premature_aging | 0.83691821 |
| 129 | MP0000377_abnormal_hair_follicle | 0.83323672 |
| 130 | MP0009333_abnormal_splenocyte_physiolog | 0.83210917 |
| 131 | MP0004947_skin_inflammation | 0.83067449 |
| 132 | MP0004272_abnormal_basement_membrane | 0.82937570 |
| 133 | MP0004197_abnormal_fetal_growth/weight/ | 0.82736859 |
| 134 | MP0002429_abnormal_blood_cell | 0.82457908 |
| 135 | MP0005084_abnormal_gallbladder_morpholo | 0.81849936 |
| 136 | MP0003011_delayed_dark_adaptation | 0.81658632 |
| 137 | MP0001881_abnormal_mammary_gland | 0.81454549 |
| 138 | MP0005451_abnormal_body_composition | 0.80365513 |
| 139 | MP0001790_abnormal_immune_system | 0.80163636 |
| 140 | MP0005387_immune_system_phenotype | 0.80163636 |
| 141 | MP0003172_abnormal_lysosome_physiology | 0.78953312 |
| 142 | MP0009931_abnormal_skin_appearance | 0.77662906 |
| 143 | MP0001727_abnormal_embryo_implantation | 0.76985308 |
| 144 | MP0002111_abnormal_tail_morphology | 0.75992671 |
| 145 | MP0005671_abnormal_response_to | 0.75219183 |
| 146 | MP0003718_maternal_effect | 0.75170522 |
| 147 | MP0002723_abnormal_immune_serum | 0.74968360 |
| 148 | MP0009379_abnormal_foot_pigmentation | 0.74483139 |
| 149 | MP0002452_abnormal_antigen_presenting | 0.74363878 |
| 150 | MP0004087_abnormal_muscle_fiber | 0.73816706 |
| 151 | MP0000716_abnormal_immune_system | 0.72901303 |
| 152 | MP0002135_abnormal_kidney_morphology | 0.71591907 |
| 153 | MP0002132_abnormal_respiratory_system | 0.71484667 |
| 154 | MP0009278_abnormal_bone_marrow | 0.71080172 |
| 155 | MP0000477_abnormal_intestine_morphology | 0.70838059 |
| 156 | MP0002419_abnormal_innate_immunity | 0.70545802 |
| 157 | MP0008057_abnormal_DNA_replication | 0.70216010 |
| 158 | MP0006082_CNS_inflammation | 0.69539742 |
| 159 | MP0005000_abnormal_immune_tolerance | 0.67992168 |
| 160 | MP0006035_abnormal_mitochondrial_morpho | 0.67380874 |
| 161 | MP0002078_abnormal_glucose_homeostasis | 0.67348642 |
| 162 | MP0003693_abnormal_embryo_hatching | 0.67337396 |
| 163 | MP0002420_abnormal_adaptive_immunity | 0.67263611 |
| 164 | MP0002405_respiratory_system_inflammati | 0.67175276 |
| 165 | MP0005376_homeostasis/metabolism_phenot | 0.67048906 |
| 166 | MP0001819_abnormal_immune_cell | 0.66791841 |
| 167 | MP0005266_abnormal_metabolism | 0.66195324 |
| 168 | MP0009765_abnormal_xenobiotic_induced | 0.66116562 |
| 169 | MP0002928_abnormal_bile_duct | 0.65795701 |
| 170 | MP0000465_gastrointestinal_hemorrhage | 0.65259467 |
| 171 | MP0000604_amyloidosis | 0.63761617 |
| 172 | MP0004808_abnormal_hematopoietic_stem | 0.63247275 |
| 173 | MP0003866_abnormal_defecation | 0.62278421 |
| 174 | MP0010368_abnormal_lymphatic_system | 0.60062010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.89343922 |
| 2 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.28289178 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 4.21348775 |
| 4 | Xanthomatosis (HP:0000991) | 4.14862825 |
| 5 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.04043942 |
| 6 | Deep venous thrombosis (HP:0002625) | 4.02138768 |
| 7 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.83469759 |
| 8 | Hyperammonemia (HP:0001987) | 3.75303112 |
| 9 | Microvesicular hepatic steatosis (HP:0001414) | 3.74123934 |
| 10 | Ketosis (HP:0001946) | 3.72984677 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 3.70546839 |
| 12 | Hyperbilirubinemia (HP:0002904) | 3.57383814 |
| 13 | Hyperglycinuria (HP:0003108) | 3.47581897 |
| 14 | Poikilocytosis (HP:0004447) | 3.44025104 |
| 15 | Gout (HP:0001997) | 3.37247831 |
| 16 | Hypoglycemic coma (HP:0001325) | 3.31825373 |
| 17 | Acanthocytosis (HP:0001927) | 3.28195325 |
| 18 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.26686207 |
| 19 | Abnormality of glycine metabolism (HP:0010895) | 3.20055750 |
| 20 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.20055750 |
| 21 | Abnormality of purine metabolism (HP:0004352) | 3.08777413 |
| 22 | Ketoacidosis (HP:0001993) | 3.08154597 |
| 23 | Abnormality of nucleobase metabolism (HP:0010932) | 3.06455527 |
| 24 | Generalized aminoaciduria (HP:0002909) | 3.05450497 |
| 25 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.05119442 |
| 26 | Progressive muscle weakness (HP:0003323) | 3.03803457 |
| 27 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.02650649 |
| 28 | Dicarboxylic aciduria (HP:0003215) | 3.02650649 |
| 29 | Prolonged partial thromboplastin time (HP:0003645) | 3.02504810 |
| 30 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.01811755 |
| 31 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.98989993 |
| 32 | Ragged-red muscle fibers (HP:0003200) | 2.96395172 |
| 33 | Abnormality of glycolysis (HP:0004366) | 2.94944688 |
| 34 | Hyperacusis (HP:0010780) | 2.94251514 |
| 35 | Hyperglycinemia (HP:0002154) | 2.93793780 |
| 36 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.86607983 |
| 37 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.85183688 |
| 38 | Reticulocytosis (HP:0001923) | 2.83860915 |
| 39 | Hyperlipoproteinemia (HP:0010980) | 2.82156060 |
| 40 | Joint hemorrhage (HP:0005261) | 2.80691356 |
| 41 | Hepatocellular carcinoma (HP:0001402) | 2.77424620 |
| 42 | Selective tooth agenesis (HP:0001592) | 2.74734548 |
| 43 | Hypolipoproteinemia (HP:0010981) | 2.74378145 |
| 44 | Metabolic acidosis (HP:0001942) | 2.69648316 |
| 45 | Abnormality of the common coagulation pathway (HP:0010990) | 2.69289956 |
| 46 | Complement deficiency (HP:0004431) | 2.65794378 |
| 47 | Proximal tubulopathy (HP:0000114) | 2.61240384 |
| 48 | Spastic diplegia (HP:0001264) | 2.60882479 |
| 49 | Delayed CNS myelination (HP:0002188) | 2.60245403 |
| 50 | Late onset (HP:0003584) | 2.56163747 |
| 51 | Vertebral compression fractures (HP:0002953) | 2.53503777 |
| 52 | Achilles tendon contracture (HP:0001771) | 2.52653230 |
| 53 | Myopathic facies (HP:0002058) | 2.52293395 |
| 54 | Fat malabsorption (HP:0002630) | 2.50557110 |
| 55 | Increased serum pyruvate (HP:0003542) | 2.50113028 |
| 56 | Abnormality of the intrinsic pathway (HP:0010989) | 2.49290513 |
| 57 | Cholelithiasis (HP:0001081) | 2.48792052 |
| 58 | Abnormality of reticulocytes (HP:0004312) | 2.46249819 |
| 59 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.44608708 |
| 60 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.43144441 |
| 61 | Trismus (HP:0000211) | 2.43051964 |
| 62 | Reticulocytopenia (HP:0001896) | 2.42443916 |
| 63 | Increased serum ferritin (HP:0003281) | 2.41218838 |
| 64 | Testicular atrophy (HP:0000029) | 2.40048229 |
| 65 | Abnormality of iron homeostasis (HP:0011031) | 2.39912504 |
| 66 | Abnormality of the Achilles tendon (HP:0005109) | 2.39378415 |
| 67 | Abnormal gallbladder morphology (HP:0012437) | 2.36861505 |
| 68 | Nausea (HP:0002018) | 2.34220626 |
| 69 | Petechiae (HP:0000967) | 2.31747578 |
| 70 | Impaired platelet aggregation (HP:0003540) | 2.31485000 |
| 71 | Abnormal platelet function (HP:0011869) | 2.31485000 |
| 72 | Rhabdomyolysis (HP:0003201) | 2.29012813 |
| 73 | Short nail (HP:0001799) | 2.28639536 |
| 74 | Hyperuricemia (HP:0002149) | 2.28245086 |
| 75 | Increased purine levels (HP:0004368) | 2.28245086 |
| 76 | Hypoalphalipoproteinemia (HP:0003233) | 2.27242492 |
| 77 | Vomiting (HP:0002013) | 2.26316508 |
| 78 | Insomnia (HP:0100785) | 2.24170712 |
| 79 | Progressive external ophthalmoplegia (HP:0000590) | 2.22429968 |
| 80 | Lethargy (HP:0001254) | 2.21160543 |
| 81 | Polycythemia (HP:0001901) | 2.20470811 |
| 82 | Increased connective tissue (HP:0009025) | 2.18731814 |
| 83 | Hydroxyprolinuria (HP:0003080) | 2.15863891 |
| 84 | Abnormality of proline metabolism (HP:0010907) | 2.15863891 |
| 85 | Rough bone trabeculation (HP:0100670) | 2.15555137 |
| 86 | Abnormality of methionine metabolism (HP:0010901) | 2.14232401 |
| 87 | Abnormality of urine glucose concentration (HP:0011016) | 2.14215417 |
| 88 | Glycosuria (HP:0003076) | 2.14215417 |
| 89 | Distal lower limb muscle weakness (HP:0009053) | 2.13612032 |
| 90 | Flat acetabular roof (HP:0003180) | 2.12466689 |
| 91 | Autoimmune thrombocytopenia (HP:0001973) | 2.11047937 |
| 92 | Abnormality of complement system (HP:0005339) | 2.10829621 |
| 93 | Hypercholesterolemia (HP:0003124) | 2.09482911 |
| 94 | Exercise-induced myalgia (HP:0003738) | 2.08802030 |
| 95 | Epistaxis (HP:0000421) | 2.07694040 |
| 96 | Hypochromic microcytic anemia (HP:0004840) | 2.04812738 |
| 97 | Pili torti (HP:0003777) | 2.04557668 |
| 98 | Malnutrition (HP:0004395) | 2.04499495 |
| 99 | Microcytic anemia (HP:0001935) | 2.04470785 |
| 100 | Epidermoid cyst (HP:0200040) | 2.02574960 |
| 101 | Menorrhagia (HP:0000132) | 2.00704586 |
| 102 | Upper motor neuron abnormality (HP:0002127) | 1.99751668 |
| 103 | Abnormality of serum amino acid levels (HP:0003112) | 1.98208448 |
| 104 | Brushfield spots (HP:0001088) | 1.97707141 |
| 105 | Alkalosis (HP:0001948) | 1.97304580 |
| 106 | Thrombophlebitis (HP:0004418) | 1.96953527 |
| 107 | IgM deficiency (HP:0002850) | 1.96645467 |
| 108 | Broad distal phalanx of finger (HP:0009836) | 1.95892357 |
| 109 | Abnormal cartilage morphology (HP:0002763) | 1.95463256 |
| 110 | Gingival bleeding (HP:0000225) | 1.95120559 |
| 111 | Pancreatitis (HP:0001733) | 1.94879274 |
| 112 | Distal lower limb amyotrophy (HP:0008944) | 1.94744160 |
| 113 | Abnormal number of erythroid precursors (HP:0012131) | 1.94295579 |
| 114 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.93670869 |
| 115 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.91454531 |
| 116 | Systemic lupus erythematosus (HP:0002725) | 1.91296073 |
| 117 | Multiple enchondromatosis (HP:0005701) | 1.91106535 |
| 118 | Abnormal gallbladder physiology (HP:0012438) | 1.91071394 |
| 119 | Cholecystitis (HP:0001082) | 1.91071394 |
| 120 | Abnormal hair laboratory examination (HP:0003328) | 1.90882799 |
| 121 | Vacuolated lymphocytes (HP:0001922) | 1.89764871 |
| 122 | Esophageal varix (HP:0002040) | 1.89212703 |
| 123 | Neonatal onset (HP:0003623) | 1.89007601 |
| 124 | Opisthotonus (HP:0002179) | 1.88822053 |
| 125 | Back pain (HP:0003418) | 1.88378152 |
| 126 | Prolonged bleeding time (HP:0003010) | 1.88202313 |
| 127 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.88119891 |
| 128 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.86835904 |
| 129 | Long palpebral fissure (HP:0000637) | 1.86663397 |
| 130 | Premature skin wrinkling (HP:0100678) | 1.86167624 |
| 131 | Distal upper limb amyotrophy (HP:0007149) | 1.86040675 |
| 132 | Upper limb amyotrophy (HP:0009129) | 1.86040675 |
| 133 | Abnormality of the gallbladder (HP:0005264) | 1.85910279 |
| 134 | Myocardial infarction (HP:0001658) | 1.84796513 |
| 135 | Cerebral edema (HP:0002181) | 1.84733382 |
| 136 | Thrombocytosis (HP:0001894) | 1.84256391 |
| 137 | Abnormality of the umbilical cord (HP:0010881) | 1.83929658 |
| 138 | Deviation of the thumb (HP:0009603) | 1.83685033 |
| 139 | Abnormality of the thoracic spine (HP:0100711) | 1.81204035 |
| 140 | Hypokinesia (HP:0002375) | 1.80809907 |
| 141 | Pterygium (HP:0001059) | 1.76263510 |
| 142 | Diaphragmatic weakness (HP:0009113) | 1.75622866 |
| 143 | Abnormality of the calcaneus (HP:0008364) | 1.75270123 |
| 144 | Abnormal trabecular bone morphology (HP:0100671) | 1.74233851 |
| 145 | Proximal placement of thumb (HP:0009623) | 1.73989279 |
| 146 | Myoglobinuria (HP:0002913) | 1.72761518 |
| 147 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.72327614 |
| 148 | Progressive hearing impairment (HP:0001730) | 1.67729819 |
| 149 | Secondary amenorrhea (HP:0000869) | 1.67352964 |
| 150 | Spastic paraparesis (HP:0002313) | 1.66196378 |
| 151 | Premature rupture of membranes (HP:0001788) | 1.66160385 |
| 152 | Flattened epiphyses (HP:0003071) | 1.65509007 |
| 153 | Entropion (HP:0000621) | 1.65349422 |
| 154 | Ulnar bowing (HP:0003031) | 1.64874290 |
| 155 | Cortical dysplasia (HP:0002539) | 1.63103646 |
| 156 | Fasciculations (HP:0002380) | 1.63039978 |
| 157 | Generalized amyotrophy (HP:0003700) | 1.62821786 |
| 158 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.62811185 |
| 159 | Overriding aorta (HP:0002623) | 1.59698467 |
| 160 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.58847350 |
| 161 | Breast hypoplasia (HP:0003187) | 1.58029446 |
| 162 | Macrocytic anemia (HP:0001972) | 1.56790033 |
| 163 | Thoracic kyphosis (HP:0002942) | 1.55711209 |
| 164 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.54844413 |
| 165 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.54844413 |
| 166 | Increased nuchal translucency (HP:0010880) | 1.54515437 |
| 167 | Abnormality of carpal bone ossification (HP:0006257) | 1.53879975 |
| 168 | Athetosis (HP:0002305) | 1.53661896 |
| 169 | Hand muscle atrophy (HP:0009130) | 1.52251247 |
| 170 | Insidious onset (HP:0003587) | 1.51088259 |
| 171 | Termporal pattern (HP:0011008) | 1.51088259 |
| 172 | Exercise-induced muscle cramps (HP:0003710) | 1.50183922 |
| 173 | Advanced eruption of teeth (HP:0006288) | 1.49033470 |
| 174 | 11 pairs of ribs (HP:0000878) | 1.48850537 |
| 175 | Bulbar palsy (HP:0001283) | 1.48845596 |
| 176 | Seborrheic dermatitis (HP:0001051) | 1.48759767 |
| 177 | Biconcave vertebral bodies (HP:0004586) | 1.48526484 |
| 178 | Abnormality of the salivary glands (HP:0010286) | 1.47658533 |
| 179 | Disproportionate tall stature (HP:0001519) | 1.47644733 |
| 180 | Osteolytic defects of the hand bones (HP:0009699) | 1.47382644 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SMG1 | 4.20033080 |
| 2 | ERN1 | 3.98092212 |
| 3 | BCKDK | 3.87985300 |
| 4 | MAP4K1 | 3.11583334 |
| 5 | FGFR4 | 3.07762594 |
| 6 | TRIB3 | 2.94666188 |
| 7 | VRK2 | 2.75992602 |
| 8 | PKN2 | 2.63068821 |
| 9 | ICK | 2.50915680 |
| 10 | EEF2K | 2.47832506 |
| 11 | EPHA2 | 2.45444905 |
| 12 | NME2 | 2.33070156 |
| 13 | FLT3 | 2.32046444 |
| 14 | MAP3K10 | 2.31300736 |
| 15 | TYK2 | 2.23841005 |
| 16 | PBK | 2.21432435 |
| 17 | TTK | 1.96748241 |
| 18 | TAOK3 | 1.96213490 |
| 19 | GRK6 | 1.92643244 |
| 20 | SIK1 | 1.88524545 |
| 21 | LRRK2 | 1.83210476 |
| 22 | TBK1 | 1.79416581 |
| 23 | SCYL2 | 1.71218219 |
| 24 | JAK3 | 1.69899629 |
| 25 | KIT | 1.63637511 |
| 26 | EIF2AK1 | 1.60509346 |
| 27 | KDR | 1.59308192 |
| 28 | STK10 | 1.58785875 |
| 29 | MAPK11 | 1.57385730 |
| 30 | MAP2K3 | 1.56663162 |
| 31 | PRPF4B | 1.53967228 |
| 32 | TSSK6 | 1.48552318 |
| 33 | PTK6 | 1.47142555 |
| 34 | ZAP70 | 1.45166866 |
| 35 | ARAF | 1.39495383 |
| 36 | SRPK1 | 1.37351685 |
| 37 | TGFBR2 | 1.32421166 |
| 38 | BTK | 1.31606231 |
| 39 | IKBKE | 1.30460836 |
| 40 | PRKD3 | 1.26844705 |
| 41 | TESK1 | 1.24384936 |
| 42 | WNK4 | 1.24023873 |
| 43 | WNK3 | 1.20632636 |
| 44 | TGFBR1 | 1.19447761 |
| 45 | ACVR1B | 1.19174793 |
| 46 | CAMK1D | 1.14158016 |
| 47 | CSF1R | 1.12995429 |
| 48 | CDK4 | 1.12156389 |
| 49 | NME1 | 1.11636377 |
| 50 | MAP3K11 | 1.10321089 |
| 51 | PAK4 | 1.08325311 |
| 52 | LMTK2 | 1.05638241 |
| 53 | PASK | 1.04044335 |
| 54 | AURKA | 1.03929231 |
| 55 | RPS6KA4 | 1.01244099 |
| 56 | BRSK1 | 0.99822978 |
| 57 | JAK2 | 0.98526066 |
| 58 | RIPK1 | 0.98163125 |
| 59 | MAP2K2 | 0.96539021 |
| 60 | NEK1 | 0.95305124 |
| 61 | BLK | 0.91814392 |
| 62 | DYRK3 | 0.91479187 |
| 63 | PIM2 | 0.89168773 |
| 64 | SYK | 0.88942513 |
| 65 | DYRK1B | 0.88252243 |
| 66 | JAK1 | 0.88201778 |
| 67 | BRAF | 0.88114973 |
| 68 | PDK2 | 0.87778976 |
| 69 | MAP3K7 | 0.87038923 |
| 70 | RPS6KB2 | 0.86831833 |
| 71 | CHEK2 | 0.85567510 |
| 72 | MAPKAPK3 | 0.85557116 |
| 73 | PIM1 | 0.83994474 |
| 74 | MAP3K8 | 0.83560322 |
| 75 | PIK3CG | 0.83305840 |
| 76 | MAP3K3 | 0.83282490 |
| 77 | TAOK1 | 0.82219481 |
| 78 | CDK19 | 0.79791503 |
| 79 | MET | 0.78701764 |
| 80 | TTN | 0.77299766 |
| 81 | NEK2 | 0.77060486 |
| 82 | ATR | 0.75229164 |
| 83 | ILK | 0.74844780 |
| 84 | TAF1 | 0.74465702 |
| 85 | CDK6 | 0.74240683 |
| 86 | WEE1 | 0.70570478 |
| 87 | ITK | 0.67834461 |
| 88 | CDK8 | 0.67757867 |
| 89 | BMX | 0.67090165 |
| 90 | CHEK1 | 0.66039137 |
| 91 | MATK | 0.65930250 |
| 92 | CDK12 | 0.65229930 |
| 93 | PLK1 | 0.64996135 |
| 94 | TESK2 | 0.62432438 |
| 95 | NEK9 | 0.59115769 |
| 96 | LYN | 0.58345638 |
| 97 | EPHB1 | 0.57160038 |
| 98 | CAMK1G | 0.56364990 |
| 99 | CSK | 0.56084037 |
| 100 | DAPK1 | 0.55643005 |
| 101 | STK16 | 0.55091816 |
| 102 | TXK | 0.54828118 |
| 103 | CDK7 | 0.53318811 |
| 104 | FGFR3 | 0.52175209 |
| 105 | LCK | 0.51879299 |
| 106 | STK4 | 0.50466088 |
| 107 | IKBKB | 0.49794219 |
| 108 | LIMK1 | 0.48430499 |
| 109 | TEC | 0.46986295 |
| 110 | MTOR | 0.46917430 |
| 111 | ERBB4 | 0.45047172 |
| 112 | PAK1 | 0.44630493 |
| 113 | DAPK3 | 0.44611773 |
| 114 | PRKCI | 0.44142439 |
| 115 | CDC7 | 0.43375128 |
| 116 | ALK | 0.42885956 |
| 117 | LATS2 | 0.42324812 |
| 118 | ZAK | 0.41911872 |
| 119 | AURKB | 0.40725310 |
| 120 | MST1R | 0.40536931 |
| 121 | PRKAA2 | 0.40287678 |
| 122 | VRK1 | 0.39618513 |
| 123 | MYLK | 0.39367727 |
| 124 | CDK9 | 0.39130133 |
| 125 | MAPK4 | 0.39102653 |
| 126 | CHUK | 0.38515981 |
| 127 | NTRK1 | 0.37872869 |
| 128 | MUSK | 0.37332149 |
| 129 | PRKG2 | 0.37322460 |
| 130 | IRAK3 | 0.36501381 |
| 131 | PRKD2 | 0.35441636 |
| 132 | PTK2 | 0.35399911 |
| 133 | CDK11A | 0.35013583 |
| 134 | PDPK1 | 0.34237592 |
| 135 | ERBB2 | 0.34140161 |
| 136 | CDK1 | 0.33786690 |
| 137 | RPS6KA6 | 0.33451388 |
| 138 | ABL2 | 0.33391139 |
| 139 | AKT2 | 0.31741669 |
| 140 | TIE1 | 0.31154339 |
| 141 | BUB1 | 0.29720579 |
| 142 | MAP3K14 | 0.29524406 |
| 143 | PDGFRA | 0.29505257 |
| 144 | MAP2K6 | 0.28741420 |
| 145 | MAPK12 | 0.26648918 |
| 146 | TAOK2 | 0.26580700 |
| 147 | RPS6KC1 | 0.26513501 |
| 148 | RPS6KL1 | 0.26513501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33937696 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.06579582 |
| 3 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65354190 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.64028189 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.54660329 |
| 6 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.48314846 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.42136567 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.38590265 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.33623151 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.25586415 |
| 11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.15152625 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.14218204 |
| 13 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03989927 |
| 14 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.02877806 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.00290213 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.00163969 |
| 17 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.85773337 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.85612903 |
| 19 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.83803868 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.80141642 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.75634801 |
| 22 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.74481726 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.72004162 |
| 24 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.71311960 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.70112139 |
| 26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.69855156 |
| 27 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.66174469 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.64010212 |
| 29 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.60924497 |
| 30 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.54773483 |
| 31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.53224056 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.53169746 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45208910 |
| 34 | Spliceosome_Homo sapiens_hsa03040 | 1.44726370 |
| 35 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.43691788 |
| 36 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.38012434 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.37554403 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.34508381 |
| 39 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.32717515 |
| 40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.32525943 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.31865311 |
| 42 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.29497848 |
| 43 | Histidine metabolism_Homo sapiens_hsa00340 | 1.28614185 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.27337764 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.25809015 |
| 46 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.25715839 |
| 47 | Cell cycle_Homo sapiens_hsa04110 | 1.24051271 |
| 48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22767006 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.22009034 |
| 50 | RNA transport_Homo sapiens_hsa03013 | 1.21234325 |
| 51 | Bile secretion_Homo sapiens_hsa04976 | 1.16654771 |
| 52 | ABC transporters_Homo sapiens_hsa02010 | 1.16605341 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15341878 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.15059761 |
| 55 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.12162211 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 1.11626419 |
| 57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.06321451 |
| 58 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04692360 |
| 59 | DNA replication_Homo sapiens_hsa03030 | 1.02802327 |
| 60 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.02325457 |
| 61 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.01280722 |
| 62 | Thyroid cancer_Homo sapiens_hsa05216 | 1.01232335 |
| 63 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97312481 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.95183773 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95032833 |
| 66 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.94948671 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.94905655 |
| 68 | Homologous recombination_Homo sapiens_hsa03440 | 0.94582627 |
| 69 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.92855474 |
| 70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90310576 |
| 71 | RNA polymerase_Homo sapiens_hsa03020 | 0.86555357 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.82789571 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.81843921 |
| 74 | Ribosome_Homo sapiens_hsa03010 | 0.80685510 |
| 75 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.79843565 |
| 76 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.73392643 |
| 77 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.67344958 |
| 78 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.65826410 |
| 79 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64622701 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63810519 |
| 81 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.61461770 |
| 82 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59843644 |
| 83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56436797 |
| 84 | Metabolic pathways_Homo sapiens_hsa01100 | 0.53638267 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53452079 |
| 86 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.52419457 |
| 87 | Purine metabolism_Homo sapiens_hsa00230 | 0.50877512 |
| 88 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.50815047 |
| 89 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.50668757 |
| 90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.48077349 |
| 91 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.47743135 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45868196 |
| 93 | Mismatch repair_Homo sapiens_hsa03430 | 0.45822860 |
| 94 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45490854 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44336425 |
| 96 | Huntingtons disease_Homo sapiens_hsa05016 | 0.42329349 |
| 97 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.41817028 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.41602635 |
| 99 | Base excision repair_Homo sapiens_hsa03410 | 0.41478910 |
| 100 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.41381739 |
| 101 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.39238697 |
| 102 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.39179122 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.38630283 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.38601947 |
| 105 | Prion diseases_Homo sapiens_hsa05020 | 0.38148674 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.37306390 |
| 107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.37018430 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.36499046 |
| 109 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.33483742 |
| 110 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32953447 |
| 111 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32823140 |
| 112 | Shigellosis_Homo sapiens_hsa05131 | 0.32099710 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.32039820 |
| 114 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.30990099 |
| 115 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.30225006 |
| 116 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.29745780 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.29076655 |
| 118 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.28179422 |
| 119 | Legionellosis_Homo sapiens_hsa05134 | 0.24069211 |
| 120 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23754246 |
| 121 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23579891 |
| 122 | HTLV-I infection_Homo sapiens_hsa05166 | 0.23362438 |
| 123 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.23149881 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | 0.20083645 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19486365 |
| 126 | Proteasome_Homo sapiens_hsa03050 | 0.19014809 |
| 127 | Lysosome_Homo sapiens_hsa04142 | 0.18736247 |
| 128 | Measles_Homo sapiens_hsa05162 | 0.17931665 |
| 129 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.17635750 |
| 130 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.16289900 |
| 131 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.15699754 |
| 132 | Leishmaniasis_Homo sapiens_hsa05140 | 0.13512148 |
| 133 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.12283471 |
| 134 | Apoptosis_Homo sapiens_hsa04210 | 0.10825090 |
| 135 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.10659137 |
| 136 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.10535746 |
| 137 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.08314297 |
| 138 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.07396506 |

